Hepatologische Erkrankungen in der Schwangerschaft

Lebererkrankungen komplizieren etwa 5% aller Schwangerschaften. Da neben maternalen insbesondere fetale Komplikationen auftreten können, erfordern diese eine kompetente hepatologische Betreuung in enger interdisziplinärer Kooperation mit dem Geburtshelfer. Der Artikel stellt die schwangerschaftsspezifischen Lebererkrankungen, die klinisch relevanten Aspekte koinzidenter und präexistenter Lebererkrankungen sowie die Besonderheiten im Rahmen der Schwangerschaft zusammen.

Schlüsselwörter

Eklampsie - HELLP-Syndrom - Nukleotidanalogon - Schwangerschaftscholestase - Schwangerschaftsfettleber - Ursodeoxycholsäure - Virushepatitis

• Literatur

• 1 Schutt VA, Minuk GY. Liver diseases unique to pregnancy. Best Pract Res Clin Gastroenterol 2007; 21: 771-792
• 2 Joshi D, James A, Quaglia A. et al. Liver disease in pregnancy. Lancet 2010; 375: 594-605
• 3 Duraiswamy S, Sheffield J, McIntire D. et al. The change in etiology of hyperbilirubinemia in pregnancy over the last 35 years. Hepatology 2012; 56: 550A
• 4 Pusl T, Beuers U. Intrahepatic cholestasis of pregnancy. Orphanet J Rare Dis 2007; 2: 26
• 5 Mullenbach R, Linton KJ, Wiltshire S. et al. ABCB4 gene sequence variation in women with intrahepatic cholestasis of pregnancy. J Med Genet 2003; 40: e70
• 6 Dixon PH, van Mil SW, Chambers J. et al. Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy. Gut 2009; 58: 537-544
• 7 Van Mil SW, Milona A, Dixon PH. et al. Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. Gastroenterology 2007; 133: 507-516
• 8 Reyes H, Sjovall J. Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy. Ann Med 2000; 32: 94-106
• 9 Debry P, Nash EA, Neklason DW. et al. Role of multidrug resistance P-glycoproteins in cholesterol esterification. J Biol Chem 1997; 272: 1026-1031
• 10 Zimmer V, Mullenbach R, Simon E. et al. Combined functional variants of hepatobiliary transporters and FXR aggravate intrahepatic cholestasis of pregnancy. Liver Int 2009; 29: 1286-1288
• 11 Ropponen A, Sund R, Riikonen S. et al. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study. Hepatology 2006; 43: 723-728
• 12 Locatelli A, Roncaglia N, Arreghini A. et al. Hepatitis C virus infection is associated with a higher incidence of cholestasis of pregnancy. Br J Obstet Gynaecol 1999; 106: 498-500
• 13 Ziol M, Barbu V, Rosmorduc O. et al. ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults. Gastroenterology 2008; 135: 131-141
• 14 Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology 2004; 40: 467-474
• 15 EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009; 51: 237-267
• 16 Bacq Y, Sentilhes L, Reyes HB. et al. Efficacy of Ursodeoxycholic Acid in Treating Intrahepatic Cholestasis of Pregnancy: A Meta-analysis. Gastroenterology 2012; 143: 1492-1501
• 17 Chappell LC, Gurung V, Seed PT. et al. Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial. BMJ 2012; 344: e3799
• 18 Beuers U. Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 318-328
• 19 Hague WM, Callaway L, Chambers L. et al. A multi-centre, open label, randomised, parallel-group, superiority Trial to compare the efficacy of URsodeoxycholic acid with RIFampicin in the management of women with severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC randomised trial. BMC Pregnancy Childbirth 2021; 21: 51
• 20 Ibdah JA. Acute fatty liver of pregnancy: an update on pathogenesis and clinical implications. World J Gastroenterol 2006; 12: 7397-7404
• 21 Ibdah JA. Role of genetic screening in identifying susceptibility to acute fatty liver of pregnancy. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 494-495
• 22 Van Dyke R. The Liver in Pregnancy. In: Zakim D, Boyer TD. eds. Hepatology. A textbook of Liver Disease. Philadelphia: Saunders; 2002: 1591-1616
• 23 Sandhu BS, Sanyal AJ. Pregnancy and liver disease. Gastroenterol Clin North Am 2003; 32: 407-436 ix
• 24 Abildgaard U, Heimdal K. Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review. Eur J Obstet Gynecol Reprod Biol 2013; 166: 117-123
• 25 Clark EA, Silver RM, Branch DW. Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome?. Curr Rheumatol Rep 2007; 9: 219-225
• 26 Tallarek AC, Stepan H. [Preeclampsia and HELLP syndrome as an obstetric emergency]. Med Klin Intensivmed Notfmed 2012; 107: 96-100
• 27 Rath W, Fischer T, Klockenbusch W. Diagnostik und Therapie hypertensiver Schwangerschaftserkrankungen. Leitlinie der Arbeitsgemeinschaft Schwangerschaftshochdruck/Gestose der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe e.V. (DGGG). AWMF-Leitlinien-Register Nr. 015/018. letzte Aktualisierung 05/2008.
• 28 Ismail SK, Kenny L. Review on hyperemesis gravidarum. Best Pract Res Clin Gastroenterol 2007; 21: 755-769
• 29 Hay JE. Liver disease in pregnancy. Hepatology 2008; 47: 1067-1076
• 30 Elinav E, Ben-Dov IZ, Shapira Y. et al. Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology 2006; 130: 1129-1134
• 31 Kumar A, Beniwal M, Kar P. et al. Hepatitis E in pregnancy. Int J Gynaecol Obstet 2004; 85: 240-244
• 32 Cornberg M, Protzer U, Petersen J. et al. Prophylaxis, diagnosis and therapy of hepatitis B virus infection – the German guideline. Z Gastroenterol 2011; 49: 871-930
• 33 Shepard CW, Simard EP, Finelli L. et al. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006; 28: 112-125
• 34 Wiseman E, Fraser MA, Holden S. et al. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust 2009; 190: 489-492
• 35 ter Borg MJ, Leemans WF, de Man RA. et al. Exacerbation of chronic hepatitis B infection after delivery. J Viral Hepat 2008; 15: 37-41
• 36 Han GR, Cao MK, Zhao W. et al. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol 2011; 55: 1215-1221
• 37 Brown Jr RS, Verna EC, Pereira MR. et al. Hepatitis B virus and human immunodeficiency virus drugs in pregnancy: findings from the Antiretroviral Pregnancy Registry. J Hepatol 2012; 57: 953-959
• 38 EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol 2011; 55: 245-264
• 39 Zanetti AR, Tanzi E, Newell ML. Mother-to-infant transmission of hepatitis C virus. J Hepatol 1999; 31 Suppl 1: 96-100
• 40 Sarrazin C, Berg T, Ross RS. et al. [Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]. Z Gastroenterol 2010; 48: 289-351
• 41 Conte D, Fraquelli M, Prati D. et al. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 2000; 31: 751-755
• 42 Schramm C, Herkel J, Beuers U. et al. Pregnancy in autoimmune hepatitis: outcome and risk factors. Am J Gastroenterol 2006; 101: 556-560
• 43 Westbrook RH, Yeoman AD, Kriese S. et al. Outcomes of pregnancy in women with autoimmune hepatitis. J Autoimmun 2012; 38: J239-J244
• 44 Beuers U, Wiedmann KH, Kleber G. et al. Therapy of autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis. Consensus of the German Society of Digestive System and Metabolic Diseases. Z Gastroenterol 1997; 35: 1041-1049
• 45 Hoffmann JC, Preiss JC, Autschbach F. et al. Clinical practice guideline on diagnosis and treatment of Crohnʼs disease. Z Gastroenterol 2008; 46: 1094-1146
• 46 Lammert F, Rath W. Lebererkrankungen. In: Kainer FK. Hrsg. Facharzt Geburtsmedizin. 2. Aufl.. München: Urban & Fischer; 2011: 498-526
• 47 Ko CW, Beresford SA, Schulte SJ. et al. Incidence, natural history, and risk factors for biliary sludge and stones during pregnancy. Hepatology 2005; 41: 359-365
• 48 Gutt C, Jenssen C, Barreiros AP. et al. Aktualisierte S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV) zur Prävention, Diagnostik und Behandlung von Gallensteinen. Z Gastroenterol 2018; 56: 912-966
• 49 Ovadia C, Seed PT, Sklavounos A. et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet 2019; 393: 899-909
• 50 Di Mascio D, Quist-Nelson J, Riegel M. et al. Perinatal death by bile acid levels in intrahepatic cholestasis of pregnancy: a systematic review. J Matern Fetal Neonatal Med 2021; 34: 3614-3622